# Nuclide record nct06780670 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06780670/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06780670", "NCT06780670" ;
  schema:name "Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy"@en ;
  schema:alternateName "PSMAcTION"@en ;
  schema:description "A phase 2/3 trial testing AAA817 in prostate cancer, now recruiting."@en ;
  schema:url <https://nuclide.cc/trials/nct06780670/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06780670> ;
  nuclide:status "recruiting" ;
  nuclide:tag "ctgov-ingest" ;
  nuclide:phase "2/3" ;
  nuclide:related <https://nuclide.cc/isotopes/lu-177/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/>, <https://nuclide.cc/indications/prostate-mcrpc/> ;
  nuclide:drugs <https://nuclide.cc/drugs/aaa817/> ;
  nuclide:companies <https://nuclide.cc/companies/novartis/> .